Lite Strategy, Inc. — Director's Dealing 2016

Aug 9, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2016-08-05

Reporting Person: Zech Thomas M. (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-05	Restricted stock units	$	A	17123	Acquired		Common Stock par value $0.00000002 (17123)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the registrant's Common Stock.

F2: Each restricted stock unit becomes 100% vested on August 5, 2018. Settlement of vested restricted stock units, in shares of Common Stock, shall occur within 5 days of vesting.